Culligan, Dominic

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

de Swart, L., Reiniers, C., Bagguley, T., van Marrewijk, C., Bowen, D., Hellström-Lindberg, E., Tatic, A., Symeonidis, A., Huls, G., Cermak, J., et al. (2018) · Haematologica

Iron Metabolism and DisordersAcute Myeloid Leukemia Research

Cited by 48

The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study

Santarsieri, A., Mitchell, E., Pham, M. H., Sanghvi, R., Jablonski, J., Lee-Six, H., Sturgess, K., Brice, P., Menne, T. F., Osborne, W., et al. (2025) · The Lancet Oncology

Lymphoma Diagnosis and TreatmentMultiple and Secondary Primary Cancers

Cited by 12